SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-042210
Filing Date
2021-08-06
Accepted
2021-08-06 17:30:03
Documents
84
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q srne-10q_20210630.htm   iXBRL 10-Q 2909386
2 EX-31.1 srne-ex311_6.htm EX-31.1 17311
3 EX-31.2 srne-ex312_9.htm EX-31.2 17204
4 EX-32.1 srne-ex321_8.htm EX-32.1 14933
  Complete submission text file 0001564590-21-042210.txt   10836727

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA srne-20210630.xsd EX-101.SCH 67341
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE srne-20210630_cal.xml EX-101.CAL 71873
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE srne-20210630_def.xml EX-101.DEF 287837
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE srne-20210630_lab.xml EX-101.LAB 522109
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE srne-20210630_pre.xml EX-101.PRE 449060
10 EXTRACTED XBRL INSTANCE DOCUMENT srne-10q_20210630_htm.xml XML 2138118
Mailing Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121
Business Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121 858-203-4100
Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36150 | Film No.: 211153970
SIC: 2836 Biological Products, (No Diagnostic Substances)